Examining the Gates Foundation’s Aug 2019 purchase of BioNTech stock

Written by John Leake

Revelations in the Epstein files that Jeffrey and Bill were looking for ways to capitalize a forthcoming pandemic reminded me of my intuition in 2024 that the Gates Foundation had privileged intelligence when it purchased just over three million ordinary shares of BioNTech on August 30, 2019, before BionNTech’s IPO on October 10, 2019

Continue Reading No Comments